Ziprasidone is an atypical antipsychotic drug used to treat schizophrenia, bipolar mania, and acute agitation in schizophrenic patients. Because it antagonizes H1 receptors, it can cause somnolence. This activity outlines the indications, mechanism of action, administration methods, significant adverse effects, contraindications, monitoring, and toxicity ziprasidone, so providers can direct patient therapy successfully in instances where ziprasidone provides a benefit to patient care.

**Objectives:**
- Identify the various indications for initiating therapy with ziprasidone.
- Summarize the therapeutic mechanism of action of ziprasidone.
- Explain the adverse event profile of ziprasidone.
- Review the importance of improving care coordination among the interprofessional team to enhance care delivery for patients who can benefit from therapy with ziprasidone.